Journal of Experimental Medicine, Vol 175, 471-479, Copyright © 1992 by Rockefeller University Press

ARTICLES

cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression

G Garnier, B Ault, M Kramer and HR Colten
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Factor B (Bf), an enzyme of the alternative pathway of complement activation, is one of four major histocompatibility complex (MHC) class III genes. To ascertain the genetic mechanism for tissue-specific constitutive and regulated expression of Bf, we sequenced the regulatory regions 5' of the gene from mice of different H-2 MHC haplotypes and assessed trans-acting factors, specific DNA binding nucleoproteins, in liver and kidney. Striking tissue-specific differences in constitutive expression of Bf were demonstrated in mice of H-2f or H-2z haplotypes when compared with H-2d or H-2u (kidney and intestinal Bf in H-2d or H-2u much greater than H-2f or H-2z). These differences correlated with a point nucleotide substitution 3 bp downstream of the upstream Bf initiation site that affects interaction with a DNA binding protein. This and additional cis differences localize the sequence substitutions responsible for previously identified restriction fragment length polymorphisms among inbred mouse strains and also reveal two previously unrecognized polymorphisms generated by SmaI and HinfI digestion. Evidence for differences in trans was found in a comparison of DNA binding nucleoproteins from kidney, but not liver, of B10.PL when compared with B10.M. These data, together with the high degree of sequence homology between human and mouse Bf 5' flanking regions, should prompt a search for polymorphic restriction sites and cis binding elements in the Bf promoter that could serve as markers of human MHC-associated renal pathology and variants in local MHC class III gene expression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Lalli, P. N., Strainic, M. G., Lin, F., Medof, M. E., Heeger, P. S. (2007). Decay Accelerating Factor Can Control T Cell Differentiation into IFN-{gamma}-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production. J. Immunol. 179: 5793-5802 [Abstract] [Full Text]  
• Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W. Jr., Carroll, M. C., Volanakis, J. E. (2001). Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 10.1073/pnas.261428398v1 [Abstract] [Full Text]  
• Ault, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A., Colten, H. R. (1997). Human Factor H Deficiency. MUTATIONS IN FRAMEWORK CYSTEINE RESIDUES AND BLOCK IN H PROTEIN SECRETION AND INTRACELLULAR CATABOLISM. J. Biol. Chem. 272: 25168-25175 [Abstract] [Full Text]  
• Matsumoto, M., Fukuda, W., Circolo, A., Goellner, J., Strauss-Schoenberger, J., Wang, X., Fujita, S., Hidvegi, T., Chaplin, D. D., Colten, H. R. (1997). Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94: 8720-8725 [Abstract] [Full Text]  
• Garnier, G., Circolo, A., Colten, H. R. (1996). Constitutive Expression of Murine Complement Factor B Gene Is Regulated by the Interaction of Its Upstream Promoter with Hepatocyte Nuclear Factor 4. J. Biol. Chem. 271: 30205-30211 [Abstract] [Full Text]  
• Akama, H., Johnson, C. A. C., Colten, H. R. (1995). Human Complement Protein C2. J. Biol. Chem. 270: 2674-2678 [Abstract] [Full Text]  
• Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W. Jr., Carroll, M. C., Volanakis, J. E. (2001). Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 98: 14577-14582 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS